Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
This is a study to assess the efficacy and safety of 8 weeks of treatment with
Dexlansoprazole modified release (MR)(60 mg daily and 90 mg daily) compared to Lansoprazole
(30 mg daily) in healing subjects with endoscopically proven erosive esophagitis.